Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
Abstract In Japan, the choice of anti-diabetic medication is officially recommended according to the patient’s glycemic condition and disease phenotype, unlike most other regions where metformin is recommended as the first-line medication. There has been an increase in the number of available glucos...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2019-02-01
|
| Schriftenreihe: | Cardiovascular Diabetology |
| Schlagworte: | |
| Online-Zugang: | http://link.springer.com/article/10.1186/s12933-019-0834-0 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|